C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01) A61K 31/495 (2006.01) C07D 401/04 (2006.01)
Patent
CA 2307114
A class of novel arylpiperazines is disclosed useful as serotonin reuptake inhibitors and 5-HT1D.alpha. receptor antagonists.
L'invention concerne une classe de nouvelles arylpipérazines utiles comme inhibiteurs de la réabsorption de sérotonine et comme antagonistes du récepteur 5HT1D.alpha..
Walker Clint Duane
Wong David Taiwai
Xu Yao-Chang
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Arylpiperazines as serotonin reuptake inhibitors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylpiperazines as serotonin reuptake inhibitors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylpiperazines as serotonin reuptake inhibitors and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1799121